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Despite the best conservative measures available for the control of major variceal hemorrhage, some
patients either continue to bleed, or rebleed early, and require emergency surgery. One hundred patients
with cirrhosis and uncontrolled bleeding were treated with emergency portasystemic shunts between 1968
and 1983. Fifty eight patients had end-to-side portacaval shunts and 42 hadDacron interposition mesocaval
shunts. Both groups were comparable with respect to age, sex and prevalence of alcoholism. There was an
increased severity of liver disease as assessed by Child’s class in the mesocaval group of patients.
Overall in-hospital mortality was 31% with no significant difference demonstrated between the
mesocaval group (28%) and the portacaval group (33%), nor between alcoholic cirrhotics (34%) and non-
alcoholic cirrhotics (21%). Mortality rates based on severity of liver disease were: Child’s A (1/6) 17%,
Child’s B (9/48) 19%, and Child’s C (21/46) 46%. There was a statistically significant difference between
Child’s A & B and Child’s C (p < 0.01). Four patients were lost to follow-up. No significant differences
were found in 5 year survival by life table analysis comparing portacaval (39%) vs. mesocaval (28%) groups
or alcoholic cirrhotics (36%) vs. non-alcoholic cirrhotics (29%). Encephalopathy in survivors was absent in
46%, mild in 28% and severe in 26% of patients. There was no significant difference in encephalopathy
rates following portacaval or mesocaval shunting.
Neither operation was clearly superior and choice of operation can be made on the basis of technical and
anatomical factors and surgeon experience. Emergency shunting remains a useful option for patients with
variceal bleeding refractory to other more conservative therapy, and is associated with acceptable early
mortality and long term survival rates.
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INTRODUCTION
The treatment of variceal hemorrhage remains a difficult and challenging problem.
Most patients stop bleeding either spontaneously or with non-operative
management including Pitressin, balloon tamponade and injection sclerotherapy.
Some patients however, either continue to bleed, or rebleed after initial control and
may require emergency surgical intervention to stop the bleeding. Although porta-
systemic shunting remains the standard surgical management in this situationa’2’3,
there is less agreement as to which shunt is best. The mesocaval shunt has been
preferred by some4’5’6’7’8 because it is felt to leave a lower encephalopathy rate; and
discouraged by others9’1’1a because of its higher thrombosis rate. This report
documents our experience with mesocaval and portacaval shunting for refractory
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variceal bleeding over a 16 year period and examines postoperative mortality, en-
cephalopathy and long term survival.
METHODS
Between 1968 and 1983, 100 patients with biopsy proven cirrhosis and variceal
bleeding underwent emergency portasystemic shunting. These were patients who
continued to bleed despite medical management including attempted correction of
coagulopathy, IV Pitressin, balloon tamponade and injection sclerotherapy; or had
early recurrent uncontrolled bleeding. All patients received at least 6 units of blood
prior to operation. Those patients who stopped bleeding were operated on electively
(subsequent admission) or urgently (same admission) and some of this group have
formed the basis of previous reports3’12’29. More recently, injection sclerotherapy
has been used as long term primary elective therapy for variceal bleeding with shunt
procedures reserved for failures.
Patients were denied emergency shunt surgery if they were comatose or had
severe coagulopathy refractory to the administration of coagulation factors. Also
excluded were those patients with clinical or histological (> 10% Mallory’s hyaline)
evidence of alcoholic hepatitis. This group of non-shunted patients received either;
no therapy (if moribund), transhepatic coronary vein embolization, establishment
of transhepatic portasystemic shunt, or other non-shunt surgical procedures.
In the 100 patients having emergency shunts, pre-operative endoscopy was
carried out in 75, liver biopsy in 85 and angiography in 60 patients. The mean age
of patients was 54 years with a range of 23 to 76 years. Seventy six patients had
alcoholic cirrhosis and 24 had post-necrotic cirrhosis. Hepatic functional reserve
was assessed according to the method of Child and Turcotte. Six patients were
categorized Child’s class A, 48 were considered class B, and 46 were considered
class C. All classifications were done during a bleeding episode since only cases of
ongoing refractory bleeding form the basis of this report.
Shunt selection was left up to each of three operating surgeons. Each surgeon
performed both types of shunts and choice of procedure depended primarily on
intra-operative assessment of ease of particular operation. There was a tendency
for patients with massive ascites to undergo mesocaval shunting, and this may
account in part for the higher number of Child’s C patients in the mesocaval group
(see below). In addition, 24 patients were entered into a randomized trial of
mesocaval versus portacaval shunting for refractory bleeding. These patients have
not been separately reported because it was felt that there were insufficient
numbers to draw any conclusions.
Fifty eight patients had end-to-side portacaval shunts and 42 patients had H-graft
interposition mesocaval shunts using large diameter (18-20 mm) Dacron Weave-
knit grafts. Table 1 outlines characteristics of these 2 groups of patients. The only
demographic difference between the two groups was a higher proportion of Child’s
C patients in the mesocaval group.
All patients were followed up in a combined medical surgical shunt clinic. Long
term follow-up in less than 10% of cases required correspondence with family or
referring physicians. Four patients were lost to follow-up. Encephalopathy was de-
termined at shunt clinic visits and during subsequent hospital re-admissions by
history, physical exam and trail testing. Patients with mild abnormalities on trail
testing were considered as having mild encephalopathy. Encephalopathy inducedEMERGENCY PORTASYSTEMIC SHUNTING 109
Table 1 Characteristics of Shunted Patients
Mesocaval Portacaval
n=42 n=58
males
females
Child’s class:
A
B
C
Alcoholic
Non-alcoholic
n(%) n(%)
29 (69%) 34 (59%)
13(31%) 24(41%)
1(2%) 5(8%)
16 (38%) 32 (55%)
25 (60%) 21 (37%)
32 (76%) 44 (76%)
10(24%) 14(24%)
age (mean) 55 years 54 years
by recurrent GI bleeding or as part of terminal hepatic failure is not considered in
the assessment of functional results. Otherwise we termed encephalopathy as
"mild" if easily managed, did not interfere with normal function and did not require
hospitalization. Encephalopathy was termed "severe" if it interfered with daily
activities or required hospitalization for control.
RESULTS
A] Mortality:
Overall in-hospital mortality was 31 to 100 patients. This included a few patients
who lived longer than 30 days but died in the initial hospitalization. Mortality of
alcoholic cirrhotics was 26 of 76 patients (34%) and of non-alcoholic cirrhotics 5
of 24 patients (21%). Although a trend was noted towards improved survival in
non-alcoholics it was not statistically significant (2 0.96 p > 0.05). Mortality
based on severity of liver disease as assessed by Child’s class is outlined in Table
2. Of six Child’s A patients, one died (17%). Nine of 48 Child’s B (19%) and 21
of 46 Child’s C (46%) died post-operatively. The difference between Child’s classes
A plus B and Child’s class C is statistically significant (B 7.33, p < 0.01). There
was no difference in the overall operative mortality of the mesocaval group (12 of
42 patients; 28%) and the portacaval group (19 of 58 patients; 33%). Similarly,
there were no differences in the operative mortalities between mesocaval or
portacaval groups stratified for Child’s classification.
Table 2 Operative Mortality vs Child’s Class and Shunt Type
Mesocaval Portacaval Both Shunts
# pt deaths # pt deaths # pt deaths
n n(%) n n(%) n n(%)
Child’sA 0 (0) 5 (20) 6 1" (17)
B 16 3 (19) 32 6 (19) 48 9* (19)
C 25 9 (36) 21 12 (57) 46 21" (46)
All PTS: 42 12-(28) 58 19-(33)
difference between Child’s class A & B and class C statistically significant (2 7.33, p < 0.01)
significant (X .053, p > 0.05).
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Figure 1 Kaplan-Meier estimated five year survival versus Child’s classification. Child’s A- 50%,
Child’s B- 41%, Child’s C- 27%. Difference between Child’s B and Child’s C is statistically signifi-
cant by a log rank analysis, DF=I, L=6.96, P<0.01. Numbers above graphs represent patients being
followed at the beginning of each interval.
B] Long term survival:
Analysis of survival is by the actuarial life table method. Different populations are
compared by log rank analysis. Survival curves based on Child’s class are shown in
Figure 1. Estimated 5 year survival figures are: Child’s A 50%, Child’s B 41%,
and Child’s C 27%. The difference in survival between Child’s B and Child’s C
is statistically significant (dr=l, L=6.96, P<0.01). This difference however, is due
to the disparity of initial operative mortality as demonstrated by analysis of patients
who survived operation and left hospital (Figure 2), where no difference in long
term survival is seen. Similarly there was no difference in long term survival found
by comparing alcoholic cirrhotics with non-alcoholic cirrhotics (Figure 3), or
mesocaval shunted patients with portacaval shunted patients (Figure 4).
C] Encephalopathy:
Prior to surgery, a history of chronic encephalopathy was absent in 71 patients.
Thirteen patients had historical evidence of mild encephalopathy, and 10 patients
had a history of severe encephalopathy. Information is incomplete in the remaining
9 patients. None of the patients had baseline preoperative trail testing prior to their
presentation with refractory bleeding.EMERGENCY PORTASYSTEMIC SHUNTING 111
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Figure 2 Long term survival of patients who leave hospital. No significant difference by log rank
analysis between Child’s B and Child’s C patients. Apparent difference in Figure 1 due to operative
mortality. Numbers above graphs represent patients being followed at the beginning of each interval.
Sixty five of the 69 hospital survivors have been followed up at the shunt clinic.
Thirty patients (46%) have had no encephalopathy. Eighteen patients (28%) have
had mild encephalopathy managed as an out-patient with dietary control.
Seventeen patients (26%) have had "severe" encephalopathy requiring hospitaliza-
tion for management, or significantly affecting their normal lifestyle. There has
been no difference in the incidence or severity in encephalopathy between the two
types of portasystemic shunts as outlined in Table 3. Particularly noted is the
incidence of severe encephalopathy of 25% in the tnesocaval group as compared
with 27% in the portacaval group.
Assessment of change in encephalopathy from pre-operative status is somewhat
Table 3 Encephalopathy in Hospital Survivors
Mesocaval Portacaval Both Shunts
n=28 n=37 n=65
n (%) n (%) n (%)
ABSENT 15" (54)
MILD 6* (21)
SEVERE 7* (25)
difference not significant (2 1.31, dr=2, p=.52).
15" (41) 30 (46)
12" (32) 18 (28)
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Figure 3 Kaplan-Meier estimated a five year survival of alcoholic cirrhotics and nonalcoholic
cirrhotics. No significant difference by log rank analysis. Numbers above graphs represent patients being
followed at the beginning of each interval.
obscured by the fact that results of trail testing are not available pre-operatively
for comparison. With this proviso aside, we found that in the 69 patients surviving
shunt surgery; 28 (40.6%) were unchanged, 30 (43.4%) worsened, and 6 (8.7%)
improved with regards to their pre-bleed mental status. Information is not available
in 5 (7.2%) patients.
D] Rebleeding rates:
Of the 65 operative survivors followed up on a long term basis, 15 (23%) have
been re-admitted with upper G.I. bleeding; however, on investigation, in only 2
(3%) has the bleeding been documented as coming from esophageal varices. Six
patients who rebled (including one from varices) were in the 39 patients followed
after portacaval anastomosis; and 9 patients who rebled (including the other
variceal bleed) were in the 30 patients followed after mesocaval anastomosis.
Post-mortem examinations have been performed in 11 patients in the mesocaval
group. Two patients had shunt thrombosis, one of these was the patient who died
from recurrent variceal bleeding. Four thrombosed portacaval shunts have been
found amongst 15 patients in the portacaval group who have had autopsies.EMERGENCY PORTASYSTEMIC SHUNTING 113
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Figure 4 Kaplan-Meier estimated a five year survival of portacaval and mesocaval shunted patients.
No significant difference by log rank analysis. Numbers above graphs represent patients being followed
at the beginning of each interval.
DISCUSSION
Is there still a role for emergency portasystemic shunting in cirrhotics with variceal
bleeding? There is a lack of stastical evidence to support improved long term
survival after portasystemic shunting13’14’15’16, and most reports indicate significant
mortality rates (20-82%) in patients undergoing emergency shunt opera-
11 17.18 19 tions These factors along with recent data demonstrating improved control
of variceal bleeding using esophageal sclerotherapy2’21, has led to a reluctance to
use emergency shunt surgery. There is however, still a significant incidence of
failure of medical management (including sclerotherapy), with persistant
hemorrhage contributing to patient death as reported in sclerotherapy arms of
22 o recent controlled trials. Cello described 13 of 28 patients (47 Yo) who died due to
bleeding causes despite sclerotherapy. MacDougall
2 attributed 4 deaths in 51
sclerosed patients (8%) to refractory hemorrhage. In Rikker’s trial23 of
sclerotherapy vs distal splenorenal shunt, 6 of 30 patients in the sclerotherapy arm
died of bleeding. It is these patients who fail medical management that should be
considered for emergency surgery.
Other surgical approaches to the emergency control of bleeding are still
24 25 unproven. Esophageal transection procedures have operative mortality rates as
high as shunts and as yet undetermined long term rebleeding rates. The extensive114 D.I. SOUTTER et al.
devascularization described by Sugiura
26 has a low operative mortality and en-
cephalopathy rate based on a non-alcoholic Japanese population, but has not been
duplicated in the North American setting. We have considered as unsuitable for
operation most patients with frank coma, uncorrectable coagulopathy, hepatorenal
failure or clinical or histological severe alcoholic hepatitis. These patients are
treated with transhepatic coronary vein embolization, transhepatic radiological
shunt, esophageal transection or devascularization.
Despite this selection, our mortality in Child’s C patients remains 46%. The
salvage in these 46 poor risk patients however, was satisfactory with a projected 5
year survival rate of 27%; two Child’s C patients are still alive at 7 and 10 years.
There was no demonstrable difference in operative mortality of alcoholic cirrho-
tics (34%) and non-alcoholic cirrhotics (21%). Similarly, we found no difference
in long term survival between non-alcoholic and alcoholic cirrhotics after
emergency shunting. Although some have found improved long term survival in
non-alcoholics after effective distal splenorenal shunt27’28, this does not appear to
hold true after total shunts29.
Encephalopathy in survivors was present in 54% of patients, and was similar in
portacaval and mesocaval shunt patients. We have previously shown that the
mesocaval shunt functions as a total shunt hemodynamically
3 and one would not
expect any difference in post-shunt encephalopathy rates. This rate is similar to
that reported by others after total shunting1. In 26% of patients encephalopathy
interfered with activities of daily living or required hospitalization, but 74% of
patients followed had either no encephalopathy (46%) or little disability (28%).
We have not been able to predict the occurrence of "severe" encephalopathy by
any pre-op parameter in any of this group of emergency shunted patients, or other
groups reported from this institution3’12.
We feel therefore, that there remains an important role for emergency porta-
systemic shunting in patients who are truly refractory to non-operative therapies
to stop their bleeding, and that persistant use of non-surgical therapy in such
patients is not warranted.
There remains controversy as to which type of shunt is best suited for emergency
portasystemic decompression. The interposition mesocaval shunt was enthusiasti-
cally adopted in the 1970’s, because of reports suggesting that it had a lower en-
cephalopathy rate5’7’8. A randomized trial in the elective setting did not bear out
9 this claim. There has been only one randomized trial of emergency interposition
mesocaval shunting which "favoured portacaval shunting" but the numbers were
small and the data influenced by an unexplained high (72%) operative mortality
rate in the mesocaval shunt patients, most of whom were Child’s class A or B1.
Most other authors report far less operative mortality with emergency mesocaval
shunting4’5’6’1, and are in close agreement to the rate of 28% in this series.
Although we found no difference between this operative mortality and the rate of
33% in the portacaval group, the groups had unequal numbers of Child’s class B
and C patients. Survival should have been prejudiced against the mesocaval group
which had more class C and fewer class B patients. In fact, the mortality rate of
Child’s C patients was lower in the mesocaval group (36%) than in the portacaval
group (57%); but the differences are not significant.
The main disadvantage of the mesocaval shunt is the reported incidence of late
shunt thrombosis and variceal rebleeding7’1’31. Although we have studied most
patients with early post-operative angiography, we do not have long term radio-
logical follow-up except where clinically indicated. In our mesocaval groupEMERGENCY PORTASYSTEMIC SHUNTING 115
however, only 1 of 30 patients who left hospital later rebled from varices; and of
11 patients who had an autopsy, 2 had shunt thrombosis. It does not seem that
repeated variceal bleeding after mesocaval shunting has been a major clinical
problem and this fact is also borne out by a similar 5 year survival with the porta-
caval shunted patients.
In summary, we found no significant difference in the operative mortality, long
term survival or incidence of encephalopathy between these two types of shunts in
100 patients operated on as an emergency. There are certain situations when a
mesocaval shunt is preferable to an end-to-side portacaval shunt. These include
patients with intractable ascites, reversal of portal flow, and where technical consid-
erations make portacaval shunting extremely difficult. Where these situations do
no exist, our current recommendation would be to do the shunt with which the
surgeon has the most experience or which is technically easier in the individual
patient.
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INVITED COMMENTARY
In this issue of HPB Surgery, Soutter and colleagues from the University of
Toronto present their experience with 100 emergency portal-systemic shunts ac-
cumulated over an interval of 15 years. These surgeons adhered to a policy of
selective emergency surgery performed only after intravenous vasopressin infusion,
balloon tamponade, and in more recent years, endoscopic sclerotherapy had failed
to control acute variceal hemorrhage. End-to-side portacaval and interposition
mesocaval shunts were utilized with shunt selection based mainly on the presence
or absence of advanced ascites. Despite more Child’s C patients undergoing the
interposition shunt, overall results were approximately equivalent after both proce-
dures with respect to operative mortality, long-term survival, postoperative en-
cephalopathy, and recurrent variceal hemorrhage. As would be expected with
totally diverting, nonselective shunts, encephalopathy complicated the post-
operative courses of 54% of patients and was severe in 26% of patients. Consider-
ing prior publications: reporting a high incidence of late shunt thrombosis after the
interposition mesocaval shunt, the frequency of recurrent hemorrhage was
surprisingly low with only one case documented in each shunt group. Compatible
with numerous prior reports, operative mortality rates were related to Child’s class
rather than to the procedure selected. Even though many of the patients were
desperately ill, long-term salvage was impressive in patients with both alcoholic
and nonalcoholic cirrhosis. This excellent series from Toronto rekindles two long
standing controversies regarding emergency surgery for patients with bleeding
varices" 1) When is the optimal time for surgical intervention? and 2) What is the
preferred operative procedure in the emergency setting?EMERGENCY PORTASYSTEMIC SHUNTING 117
In most centers, emergency surgery has played less of a role in management of
acute variceal hemorrhage as more effective nonoperative interventions, such as
endoscopic sclerotherapy, have become available. The majority of portal hyper-
tension surgeons would agree with a policy of selective emergency surgery similar
to the one presented by Soutter and associates. Whenever possible, acute bleeding
should be controlled with nonoperative means, allowing time for optimization of
hepatic function and nutritional status prior to elective surgery. An interval of
medical management may be especially important in patients with alcoholic
hepatitis, who may be at particularly high risk for postoperative morbidity or mor-
tality.
3 One study has shown that Child’s class, and therefore, operative risk, can
be significantly improved when a period of conservative treatment precedes
surgery.
4 With the availability of endoscopic sclerotherapy in most institutions,
acute episodes of variceal hemorrhage can generally be controlled without surgery
in more than 80% of instances.
Orloff is one of the few remaining advocates of routine emergency surgery for
all patients who bleed from varices. He believes that the maximum number of
patients can be salvaged by operating within eight hours of admission to the
hospital before adverse consequences of hemorrhage such as further hepatic
functional deterioration ensue. He has reported an overall operative mortality rate
of 42% (17% in recent years) in 180 consecutive emergency portacaval shunts.
Orloff’s group has conducted the only randomized, controlled trial of conservative
management followed by elective shunt surgery versus emergency portacaval shunt
6 for acutely bleeding patients. The results of their trial, which have only been
published in abstract form, reveal superior bleeding control (100% vs 45%) and
lower early mortality (19% vs 55%) in the emergency portacaval shunt group.
However, sclerotherapy was not used in the conservative treatment arm of the
study and the two nonoperative treatments used, vasopressin infusion and balloon
tamponade, were considerably less effective than in most other series. Therefore,
despite the results of this investigation, selective emergency surgery, reserved for
those few patients who fail all nonoperative attempts at control of acute variceal
bleeding, rather than routine emergency surgery is preferred by the majority of
physicians and surgeons who treat this challenging problem.
When emergency surgery is required, it remains controversial as to which
procedure should be done. I believe that an important guiding principle is that an
individual surgeon should select a familiar operation which can be completed ex-
peditiously. The emergency setting is not the time to learn or experiment with new
procedures. Because of its relative simplicity and the brief operating time required,
esophageal transection with the end-to-end anastomosis (EEA) stapler is the
emergency operation of choice for many surgeons. However, there is little evidence
that this procedure is followed by a lower operative mortality rate than shunt
operations and significant disadvantages of esophageal transection include a high
frequency of recurrent hemorrhage, complete ineffectiveness in patients with
bleeding gastric varices or portal hypertensive gastropathy, and a potentially
tenuous stapled anastomosis in patients who have received recent, intensive
sclerotherapy.
7
The most frequently used emergency shunts are the end-to-side portacaval shunt
and the interposition mesocaval shunt, the procedures selected by Soutter and col-
leagues. Although they found these operations to be approximately equivalent,
others have reported more frequent early and late recurrent hemorrhage after the118 D.I. SOUTTER et al.
interposition mesocaval shunt. 2’8 Both of these shunts totally divert portal flow and
are, therefore, frequently complicated by postoperative encephalopathy. Since the
interposition shunt decompresses hepatic sinusoids as well as the splanchnic venous
circulation, it is more effective for relief of postoperative ascites than the end-to-
side portacaval shunt. Other potential advantages of the interposition procedure
are avoidance of dissection in the porta hepatis, making subsequent liver trans-
plantation more feasible, and easy reversibility if intractable encephalopathy
should develop.
When surgery is urgent rather than emergent (e.g. bleeding temporarily con-
trolled by balloon tamponade), I believe that a distal splenorenal shunt, which has
the potential of preserving hepatic portal perIusion in addition to decompressing
varices, is a reasonable alternative. If the surgeon is experienced in performing
this procedure, the operative mortality rate appears to be similar to other
emergency operations. Visceral angiography should precede surgery in all patients
undergoing the distal splenorenal shunt, and this operation should not be selected
for patients with ascites intractable to medical management or with a splenic vein
less than 8 mm in diameter. Although some patients with a patent selective shunt
may develop recurrent hemorrhage secondary to renal vein hypertension, bleeding
is usually not life-threatening and is limited to the early postoperative interval.
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